Generic lenacapavir HIV prevention shot wins US FDA approval

The US FDA has approved a generic version of lenacapavir, a twice-yearly HIV prevention injection, increasing access to preventative treatment in the United States.

This Wire brief sits within Fusion42's coverage of Drug Discovery, and 4 sources have reported it between 2 Nov 2026 and 3 Nov 2026.